Gvsr Pharma Private Limited

Manufactures chemicals, compounds, and pharmaceuticals since 2019.

2019 | Hyderabad, Telangana (India) | Active
Last Updated: January 10, 2025

Gvsr Pharma Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024

About Gvsr Pharma

Gvsr Pharma Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 October 2019 (Five years and three months 18 days old ). Its registered office is in Hyderabad, Telangana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Venkateswara Ganesula and Seetaramaiah Chalamalasetti serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24304TG2019PTC136198

  • Company No.

    136198

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    18 Oct 2019

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

Who are the key members and board of directors at Gvsr Pharma?

Board Members (2)

Name Designation Appointment Date Status
Seetaramaiah Chalamalasetti Country flag representing In Director 13-Nov-2019 Current
Venkateswara Ganesula Country flag representing In Director 18-Oct-2019 Current

Financial Performance of Gvsr Pharma.

Gvsr Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Gvsr Pharma?

In 2020, Gvsr Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Gvsr Pharma?

Unlock and access historical data on people associated with Gvsr Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gvsr Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gvsr Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Gvsr Pharma

Recent activity within the organization

  • Annual General Meeting

    Gvsr Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Gvsr Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

    31 Mar 2024

  • Director Appointment

    Seetaramaiah Chalamalasetti was appointed as a Director was appointed as a Director on 13 Nov 2019 & has been associated with this company since 5 years 2 months .

    13 Nov 2019

  • Director Appointment

    Venkateswara Rao Ganesula was appointed as a Director was appointed as a Director on 18 Oct 2019 & has been associated with this company since 5 years 3 months .

    18 Oct 2019

  • Company Incorporation

    Gvsr Pharma Private Limited was registered on 18 Oct 2019 with Roc Hyderabad & aged 5 years 3 months as per MCA records.

    18 Oct 2019

Frequently asked questions

  • Gvsr Pharma Private Limited was incorporated on 18 Oct 2019.

  • The authorized share capital of Gvsr Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Gvsr Pharma Private Limited.

    • Venkateswara Rao Ganesula
    • Seetaramaiah Chalamalasetti
  • As per Ministry of Corporate Affairs (Mca), the registered address of Gvsr Pharma Private Limited is H.No.3-6-38/3 Second Floor Plot No.470 Vivekananada Nagar Colony, Kukatpally India, Hyderabad, Telangana, 500072.

  • The corporate identification number (CIN) of Gvsr Pharma Private Limited is U24304TG2019PTC136198 and the company number is 136198 as per Ministry of Corporate Affairs (MCA).

  • The most recent Balance Sheet for Gvsr Pharma Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development